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Abstract
Background: b-lapachone (b-lap) is a bioreductive agent that is activated by the two-electron reductase NAD(P)H quinone
oxidoreductase 1 (NQO1). Although b-lap has been reported to induce apoptosis in various cancer types in an NQO1-
dependent manner, the signaling pathways by which b-lap causes apoptosis are poorly understood.
Methodology/Principal Findings: b-lap-induced apoptosis and related molecular signaling pathways in NQO1-negative
and NQO1-overexpressing MDA-MB-231 cells were investigated. Pharmacological inhibitors or siRNAs against factors
involved in b-lap-induced apoptosis were used to clarify the roles played by such factors in b-lap-activated apoptotic
signaling pathways. b-lap leads to clonogenic cell death and apoptosis in an NQO1- dependent manner. Treatment of
NQO1-overexpressing MDA-MB-231 cells with b-lap causes rapid disruption of mitochondrial membrane potential, nuclear
translocation of AIF and Endo G from mitochondria, and subsequent caspase-independent apoptotic cell death. siRNAs
targeting AIF and Endo G effectively attenuate b-lap-induced clonogenic and apoptotic cell death. Moreover, b-lap induces
cleavage of Bax, which accumulates in mitochondria, coinciding with the observed changes in mitochondria membrane
potential. Pretreatment with Salubrinal (Sal), an endoplasmic reticulum (ER) stress inhibitor, efficiently attenuates JNK
activation caused by b-lap, and subsequent mitochondria-mediated cell death. In addition, b-lap-induced generation and
mitochondrial translocation of cleaved Bax are efficiently blocked by JNK inhibition.
Conclusions/Significance: Our results indicate that b-lap triggers induction of endoplasmic reticulum (ER) stress, thereby
leading to JNK activation and mitochondria-mediated apoptosis. The signaling pathways that we revealed in this study may
significantly contribute to an improvement of NQO1-directed tumor therapies.
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Introduction
b-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]py-
ran-5,6-dione; b-lap), a naturally occurring quinone obtained
from the bark of the Lapacho tree (Tabebuia vellanedae), has been
reported to exert a variety of pharmacological activities, such as
anti-bacterial, -fungal, -trypanocidal, and -cancer [1–2]. ARQ501
is a formulation of b -lapachone complexed with hydroxypropyl-b-
cyclodextrin for the treatment of human tumors [3]. In order to
increase the clinical efficacy of b-lap, a novel method to improve
intratumoral delivery of b-lap using polymer millirods has been
developed [3]. The anti-cancer activity of b-lap was known to be
due to two-electron reduction of b-lap mediated by NAD(P)H:
quinone oxidoreductase (NQO1, DT-diaphorase) using NADH or
NAD(P)H as electron sources [1–3]. The NQO1 is expressed
abundantly in various human solid cancers, including cancers of
the breast, pancreas, lung, and colon [1–3]. Therefore, b-lap can
selectively kill these human cancer cells that overexpress endo-
genous NQO1 [4]. Moreover, the futile cycling between the
oxidized and reduced forms of b-lap caused by NQO1 leads to
progressive depletion of NADH and NAD(P)H, which in turn
induces a massive release of Ca
2+ from Endoplasmic Reticulum
(ER) to cytosol, causing activation of calpain known as a Ca
2+
dependent proteinase and subsequent apoptosis [1,2,5].
Mitochondria-mediated apoptotic cell death has been demon-
strated to be modulated by Bcl-2 family [6]. Among Bcl-2 family,
Bax or Bak performs positive roles in the permeabilization of
mitochondrial outer membranes by participating in the formation
of pores, facilitating release of cytochrome c, apoptosis-inducing
factor (AIF), and endonuclease G (Endo G), from the intermem-
brane space of the mitochondrion to the cytosol. Cytosolic cyto-
chrome c binds to apoptotic protease-activating factor 1 (Apaf-1),
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tion; caspase-9 in turn activates caspase-3 [7]. Cleavage of the
inhibitor of caspase-activated DNase (ICAD) by caspase-3 results
in activation of caspase-activated DNase (CAD), which fragments
DNA resulting in apoptotic cell death [7–11]. Furthermore, AIF
and Endo G released from mitochondria are translocated to the
nucleus, within which these molecules trigger large-scale DNA
fragmentation, and condense chromatin, leading to apoptotic cell
death in a caspase-independent manner [10].
Diverse chemotherapeutic agents have been suggested to cause
proteolytic truncation of Bax, and trigger the mitochondrial celldeath
pathway [12–14]. In these reports, Bax is known to be truncated at
aspartate 33 by calpain, resulting in the formation of an 18 kDa
c l e a v a g ep r o d u c tt h a ti sm o r ep o t e n tt h a nn a t i v eB a xi nt e r m so f
stimulating mitochondria-mediated apoptotic cell death [15,16].
Mitogen-activated protein kinases (MAPKs), which are members
of the Ser/Thr protein kinase family, have been demonstrated to be
activated in response to a variety of external stimuli, and these
kinases participate in the regulation of cell proliferation, differen-
tiation, survival, and apoptosis [17–19]. MAPKs can be subdivided
into 3 major classes based on sequence homology: extracellular
signal-regulated kinases (ERKs), p38 MAPK, and stress-activated/
c-Jun N-terminal kinases (JNKs) [19]. ERK is commonly thought to
mediate survival when apoptotic stimuli are applied [17,20–22]. In
contrast to ERKs, JNK and p38 MAPK respond strongly to a
variety of stress signals, including those mediated by cytokines,
hyperosmotic stress, ionizing radiation, UV irradiation and chemo-
therapeutic agents, and cause apoptosis [17,20–22].
The ER is the cellular organelle responsible for biogenesis of
proteins and calcium homeostasis [23–25]. When unfolded or
Figure 1. b-lap induces NOQ1-dependnet cell death. (A) NQO1
2 or NQO1
+-MDA-MB-231 cells were treated with various concentrations of b-
lap. Cells were allowed to grow for 10 to 14 days and were stained with 0.5% crystal violet and scored for colony formation. Results from three
independent experiments are expressed as means 6 SEM. *Significant difference between NQO1
2- and NQO1
+-MDA-MB-231 cells after b-lap
treatment at p,0.05. (B) NQO1
2 or NQO1
+- MDA-MB-231 cells were treated with 5 mMo fb-lap for the indicated times. Cells were stained with PI
and the percentage of cells with a sub-G1 DNA content was measured via flow cytometric analysis. Results from three independent experiments
are expressed as the means 6 SEM. *Significant difference between NQO1
2- and NQO1
+-MDA-MB-231 cells after b-lap treatment at p,0.05. (C)
NQO1
+-MDA-MB-231 cells were treated with 5 mMo fb-lap for 18 h in the presence or absence of z-VAD-fmk (30 mM). Cells were stained with PI
and the percentage of cells with a sub-G1 DNA content was measured via flow cytometric analysis. Results from three independent experiments
are expressed as means 6 SEM. *Significant difference between the cells in the presence or absence of z-VAD-fmk after b-lap treatment at
p,0.05.
doi:10.1371/journal.pone.0021533.g001
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PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e21533Figure 2. b-lap induces cell death in AIF and Endo G-dependent manners. (A) Nuclear fractions were obtained from NQO1
+-MDA-MB-231
cells treated with 5 mMo fb-lap for the indicated times, and were subjected to Western blot analysis using anti-AIF, -Endo G, and -Nucleoporin p62
antibodies. Nucleoporin p62 was used as a nuclear marker protein. The data are representative a typical experiment conducted three times. The data
are representative of a typical experiment conducted three times with similar results. (B) Representative confocal images showing translocation of AIF
and Endo G to the nucleus, and nuclear condensation, at the indicated times after treatment with 5 mMo fb-lap. Nuclear translocation of AIF and
Endo G is demonstrated by overlap of AIF or Endo G (green) and nuclear staining (red), resulting in a yellow color. The data are representative of a
typical experiment conducted three times. (C) NQO1
+-MDA-MB-231 cells transfected with AIF or Endo G siRNA were treated with 5 mMo fb-lap. Cells
were allowed to grow for 10 to 14 days and were stained with 0.5% crystal violet and scored for colony formation. Results from three independent
experiments are expressed as means 6 SEM. *Significant difference between si-cont RNA- and si-AIF RNA-transfected cells after b-lap treatment, at
p,0.05. **Significant difference between si-cont RNA- and si-Endo G RNA-transfected cells after b-lap treatment, at p,0.05. (D) NQO1
+-MDA-MB-231
cells transfected with AIF or Endo G siRNA were treated with 5 mMo fb-lap for 18 h. Cells were stained with PI and the percentage of cells with a sub-
G1 DNA content was measured via flow cytometric analysis. Results from three independent experiments are expressed as the means 6 SEM.
*Significant difference between si-cont RNA- and si-AIF RNA-transfected cells after b-lap treatment, at p,0.05. **Significant difference between si-
cont RNA- and si-Endo G RNA-transfected cells after b-lap treatment, at p,0.05.
doi:10.1371/journal.pone.0021533.g002
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protective strategy to overcome this ER stress, termed unfolded
protein response (UPR) [23–25]. UPR is activated by ER trans-
membrane proteins, such as inositol-requiring enzyme 1 (IRE1),
pancreatic ER kinase (PERK), and activating transcription factor
(ATF) [23–26]. These proteins play a key role in increasing the
expression of various genes including GRP78 and 94 to restore ER
homeostasis [23–26]. It has been demonstrated that PERK
phosphorylates eIF2a (eukaryotic initiation factor 2a), which
subsequently activates ATF-4. Thereafter, ATF-4 induces the
expression of CHOP (C/EBP-homologous protein) and UPR
target genes [27,28]. Importantly, CHOP and phosphorylated
eIF2a have been indicated to be involved in ER stress-induced cell
death [27–29]. Furthermore, when ER stress is excessive, UPR
induces activation of IRE1/ASK1/JNK pathway which leads to
apoptotic cell death to remove severely damaged cells [15–18].
In this study, we investigated the molecular signaling mecha-
nism leading to apoptotic cell death caused by b-lap in NQO1-
overexpressing MDA-MB-231 cells. We demonstrate here that
JNK activation due to ER stress significantly contributes to mito-
chondria-mediated cell death caused by b-lap treatment. Further-
more, our results show that JNK activity is required for generation
of cleaved Bax and mitochondrial translocation of cleaved Bax in
response to b-lap treatment. Insight gained in the present study on
the molecular signaling pathway in b-lap-induced cell death will
lead to advances in establishing the strategies for NQO1-targeted
tumor treatment.
Results
b-lap induces NQO1-dependent and caspase-independent
cell death
To investigate the cell death induced by b-lap, we treated
parental NQO1
2-MDA-MB-231 cells deficient in NQO1, or
NQO1
+-MDA-MB-231 cells possessing abundant expression of
NQO1 (Fig. 1A), with different doses of b-lap, and analyzed clono-
genic cell death using a clonogenic cell survival assay. Figure 1A
shows that a dose-dependent increase in the proportion of
clonogenic cell death after b-lap treatment was evident, suggesting
that NQO1
+-MDA-MB-231 cells were more sensitive to b-lap
than parental NQO1
2-MDA-MB-231 cells. To further evaluate
whether the cytotoxic effect of b-lap was associated with induc-
tion of apoptosis, NQO1
2- or NQO1
+-MDA-MB-231 cells were
treated with 5 mMo fb-lap for various lengths of time, and then
analyzed with a sub-G1 DNA content. Figure 1B shows that a
time-dependent increase in the proportion of apoptosis after b-lap
treatment was apparent in NQO1
+-MDA-MB-231 cells, but not
in NQO1
2-MDA-MB-231 cells, suggesting that b-lap induces
apoptotic cell death in an NQO1-dependent manner.
As the activation of caspase plays a key role in the induction
of apoptotic cell death [17], we investigated whether caspase
activities are required for b-lap-induced apoptotic cell death in
NQO1
+-MDA-MB-231 cells using a broad-spectrum caspase inhi-
bitor, z-VAD-fmk. This caspase inhibitor was able to prevent
activation of caspases (data not shown) but failed to attenuate
Figure 3. b-lap causes Bax cleavage and translocation of cleaved Bax to mitochondria. (A) NQO1
+-MDA-MB-231 cells were treated with
5 mMo fb-lap for the indicated times. After 12 h, cells were loaded with 30 nM of DiOC6(3) for a further 30 min of the treatments. After removal of
medium, the concentrationof retainedDiOC6(3) was measured by flowcytometry. Resultsfrom three independent experimentsareexpressed as means
6 SEMs. *Significant difference between control and b-lap-treated cells at p,0.05. (B) NQO1
+-MDA-MB-231 cells were treated with 5 mMo fb-lap for the
indicated times. Cell lysates were subjected to Western blot analysis using anti-Bax, -Bcl-2 and -b-actin antibodies. b-actin was used as a loading control.
Thedata representa typical experiment conducted three timeswith similarresults. (C) NQO1
+-MDA-MB-231 cellswere treatedwith 5 mMo fb-lap forthe
indicated times. Mitochondrial fractions were prepared and subjected to Western blot analysis using anti-Bax and -mitochondrial HSP70 antibodies.
Mitochondrial HSP70 was used as a mitochondrial marker protein. The data are representative a typical experiment conducted three times.
doi:10.1371/journal.pone.0021533.g003
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PLoS ONE | www.plosone.org 4 June 2011 | Volume 6 | Issue 6 | e21533Figure 4. b-lap activates MAPKs in NQO1
+-MDA-MB-231 cells. (A) NQO1
+-MDA-MB-231 cells were treated with 5 mMo fb-lap for the indicated
times. Cell lysates were subjected to Western blot analysis with anti-phospho-ERK1/2, -ERK1/2, -phospho-JNK1/2, -JNK1/2, -phsopho-p38 MAPK, -p38
MAPK and b-actin antibodies. b-actin was used as a loading control. The data represent a typical experiment conducted three times with similar
results. (B) NQO1
+-MDA-MB-231 cells were treated with 5 mMo fb-lap in the presence or absence of PD98059 (30 mM), SP600125 (30 mM) or SB203580
(30 mM). Cells were allowed to grow for 10 to 14 days and were stained with 0.5% crystal violet and scored for colony formation. Results from three
independent experiments are expressed as means 6 SEM. *Significant difference between cells in the presence or absence of SP600125 after b-lap
treatment, at p,0.05. (C) NQO1
+-MDA-MB-231 cells were treated with 5 mMo fb-lap for 18 h in the presence or absence of PD98059 (30 mM),
SP600125 (30 mM) or SB203580 (30 mM). Cells were stained with PI and the percentage of cells with a sub-G1 DNA content was measured via flow
cytometric analysis. Results from three independent experiments are expressed as the means 6 SEM. *Significant difference between the cells in the
presence or absence of SP600125 after b-lap treatment at p,0.05. (D) NQO1
+-MDA-MB-231 cells were treated with 5 mMo fb-lap for 6 h in the
presence or absence of PD98059 (30 mM), SP600125 (30 mM) or SB203580 (30 mM). Cells were loaded with 30 nM of DiOC6(3) for a further 30 min of
the treatments. After removal of medium, the concentration of retained DiOC6(3) was measured by flow cytometry. Results from three independent
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that the apoptotic cell death by b-lap occurs in a caspase-
independent manner.
b-lap induces apoptotic cell death via translocation of
AIF and Endo G to the nucleus
AIF and Endo G have been known to play key roles in induc-
tion of a caspase-independent apoptotic cell death [10]. Therefore,
we next examined whether they are involved in b-lap-induced
apoptotic cell death. Subcellular fractionation showed that the
treatment of NQO1
+-MDA-MB-231 cells with b-lap dramatically
induced the translocation of AIF and Endo G to the nucleus
(Fig. 2A). Confocal microscopy also clearly showed that b-lap
treatment caused translocation of AIF and Endo G to nucleus,
and induced nuclear condensation (Fig. 2B). Moreover, siRNAs
targeting AIF and Endo G effectively attenuated the clonogenic
and apoptotic cell death caused by b-lap treatment (Fig. 2C
and D).
These results suggest that nuclear translocation of AIF and
Endo G is required for the induction of apoptotic cell death in
NQO1
+-MDA-MB-231 cells after b-lap treatment.
b-lap induces generation and translocation of cleaved
Bax to mitochondria
To assess the role of the mitochondrial pathway in induction of
apoptosis after b-lap treatment, we first investigated the changes in
mitochondrial membrane potential, and the expression levels of
Bcl-2 family proteins in NQO1
+-MDA-MB-231 cells after b-lap
treatment. As shown in Figure 3A, b-lap treatment significantly
increased the disruption of mitochondrial membrane potential in a
time-dependent manner. Simultaneously, Bax level markedly
decreased, whereas Bcl-2 level did not alter in response to b-lap
treatment (Fig. 3B).
Previously, Bax has been reported to be cleaved to an 18 kDa
fragment from 21 kDa native form in response to diverse stimuli
[15,16]. As translocation of cleaved Bax from the cytosol to mito-
chondria expedited a decline in mitochondrial membrane potential
and subsequent release of apoptogenic proteins from mitochondria
[15,16], we next determined whether b-lap treatment induces
mitochondrialtranslocationofcleavedBax. Interestingly,Figure 3C
shows that b-lap treatment effectively augmented the level of
cleaved Bax within mitochondrial fractions, in agreement with the
observed changes in mitochondrial membrane potential. However,
therewereno indicationsof presenceof18-kDacleavedform ofBax
in whole cell lysates after b-lap treatment (Fig. 3B). Since a
cathepsin-likeproteasehasbeen reported to be involved in the rapid
degradation of p18 kDa cleaved from of Bax in the cytosol [14],
cleaved Bax is thought to be readily degraded in the cytosol after
b-lap treatment.
These results indicate that an alteration in mitochondrial mem-
brane potential mediated by intracellular redistribution of cleaved
Bax is involved in b-lap-induced cell death.
JNK activation is required for theinduction of mitochondria-
mediated apoptotic cell death caused by b-lap
InordertoelucidatetheinvolvementofMAPKsinb-lap-induced
apoptotic cell death, we first analyzed the kinetics of MAPK
activation following b-lap treatment in NQO1
+-MDA-MB-231
cells. Although no changes in the total cellular levels of JNK, p38
MAPK, and ERK were evident, b-lap treatment rapidly increased
the levels of phosphorylated form of JNK, p38 MAPK, and ERK
within 30 min after b-lap treatment (Fig. 4A).
To identify the specific MAPK involved in b-lap-induced cell
death, we pretreated the cells with SP600125, SB203580, and
PD98059; inhibitors of JNK, p38 MAPK, and MEK, respectively,
prior to b-lap treatment. Interestingly, SP600125 selectively and
effectively reduced b-lap-induced clonogenic and apoptotic cell
death (Fig. 4B and C). Pretreatment with PD98059 or SB203580
slightly attenuated b-lap-mediated cellular responses in this regard
(Fig. 4B and C).
We next investigated the roles of MAPKs on mitochondria-
mediated cell death caused by b-lap treatment. Figures 4D, E, F
and G show that SP600125 was fairly more effective than either
SB203580 or PD98059 in suppressing all of b-lap-induced
disruption of mitochondrial membrane potential, Bax cleavage,
mitochondria translocation of cleaved Bax, and nuclear translo-
cation of AIF and Endo G. Confocal microscopy also clearly
showed that SP600125 efficiently blocked the nuclear transloca-
tion of AIF and Endo G induced by b-lap treatment (Fig. 4H).
Because it was obvious that JNK played a prominent role in b-
lap-induced mitochondrial apoptosis, we further determined
which JNK isoform was required for the b-lap-induced cell death
using siRNA targeting JNK1 and JNK2. As shown in Figures 5A,
B and C, siRNA targeting JNK2 efficiently attenuated b-lap-
induced clonogenic and apoptotic cell death, and dissipation of
mitochondrial membrane potential, whereas siRNA targeting
JNK1 only slightly reduced them. Furthermore, siRNA targeting
JNK2 is significantly more effective than siRNA targeting JNK1 in
blocking all of b-lap-induced mitochondrial translocation of
cleaved Bax, and nuclear translocation of AIF and Endo G
(Fig. 5D and E). These results clearly indicate that JNK2 is a
prominent mediator of b-lap-induced mitochondrial apoptosis in
NQO1
+-MDA-MB-231 cells.
ER stress induced by b-lap is required for the activation
of JNK
ER stress has been reported to trigger apoptotic cell death [23–
29]. Therefore, we assessed whether b-lap induces ER stress in
experiments are expressed as means 6 SEMs. *Significant difference between the cells in the presence or absence of SP600125 after b-lap treatment at
p,0.05. (E) NQO1
+-MDA-MB-231 cells were treated with 5 mMo fb-lap for 6 h in the presence or absence of PD98059 (30 mM), SP600125 (30 mM) or
SB203580 (30 mM). Cell lysates were subjected to Western blot analysis using anti-Bax, -Bcl-2 and -b-actin antibodies. b-actin was used as a loading
control.The datarepresenta typicalexperimentconducted three times withsimilar results.(F) NQO1
+-MDA-MB-231cells were treated with5 mMo fb-lap
for 6 h in the presence or absence of PD98059 (30 mM), SP600125 (30 mM) or SB203580 (30 mM). Mitochondrial fractions were prepared andsubjected to
Westernblotanalysisusinganti-Baxand-mitochondrialHSP70antibodies.MitochondrialHSP70wasusedasamitochondrialmarkerprotein.Thedataare
representative a typical experiment conducted three times. (G) NQO1
+-MDA-MB-231 cells were treated with 5 mMo fb-lap for 6 h in the presence or
absenceofPD98059 (30 mM), SP600125 (30 mM)or SB203580(30 mM). Nuclear fractions were preparedandsubjected toWesternblotanalysisusing anti-
AIF, -Endo G, and -Nucleoporin p62 antibodies. Nucleoporin p62 was used as a nuclear marker protein. The data are representative a typical experiment
conductedthreetimes.Thedataarerepresentativeofatypicalexperimentconductedthreetimeswithsimilarresults.(H)Representativeconfocalimages
showingtranslocationofAIFandEndoGtothenucleus,andnuclearcondensation,attheindicatedtimesaftertreatmentwith5 mMofb-lapfor6 hinthe
presence or absence of SP600125 (30 mM). Nuclear translocation of AIF and Endo G is demonstrated by overlap of AIF or Endo G (green) and nuclear
staining (red), resulting in a yellow color. The data are representative of a typical experiment conducted three times.
doi:10.1371/journal.pone.0021533.g004
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PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e21533Figure 5. The activity of JNK2 is necessarily required for mitochondria-mediated cell death caused by b-lap. (A) NQO1
+-MDA-MB-231
cells transfected with JNK1 or JNK2 siRNA were treated with 5 mMo fb-lap. Cells were allowed to grow for 10 to 14 days and were stained with 0.5%
crystal violet and scored for colony formation. Results from three independent experiments are expressed as means 6 SEM. *Significant difference
between si-cont RNA- and si-JNK2 RNA-transfected cells after b-lap treatment, at p,0.05. (B) NQO1
+-MDA-MB-231 cells transfected with JNK1 or JNK2
siRNA were treated with 5 mMo fb-lap for 18 h. Cells were stained with PI and the percentage of cells with a sub-G1 DNA content was measured via
flow cytometric analysis. Results from three independent experiments are expressed as the means 6 SEM. *Significant difference between si-cont
RNA- and si-JNK2 RNA-transfected cells after b-lap treatment, at p,0.05. (C) NQO1
+-MDA-MB-231 cells transfected with JNK1 or JNK2 siRNA were
treated with 5 mMo fb-lap for 6 h. Cells were loaded with 30 nM of DiOC6(3) for a further 30 min of the treatments. After removal of medium, the
concentration of retained DiOC6(3) was measured by flow cytometry. Results from three independent experiments are expressed as means 6 SEMs.
*Significant difference between si-cont RNA- and si-JNK2 RNA-transfected cells after b-lap treatment, at p,0.05. (D) NQO1
+-MDA-MB-231 cells
transfected with JNK1 or JNK2 siRNA were treated with 5 mMo fb-lap for 6 h. Mitochondrial fractions were prepared and subjected to Western blot
analysis using anti-Bax and -mitochondrial HSP70 antibodies. Mitochondrial HSP70 was used as a mitochondrial marker protein. The data are
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+-MDA-MB-231 cells. As shown in Figure 6A, b-lap
treatment significantly increased the phsophorylation of eIF2a
and the expression of GRP94 for 6 h. To further examine the
involvement of ER stress in b-lap-induced cell death, we
pretreated NQO1
+-MDA-MB-231 cells with Salubrinal (Sal), an
ER stress inhibitor. As shown in Figures 6B and C, pretreatment
with Sal effectively attenuated b-lap-induced clonogenic and
apoptotic cell death. We next investigated the roles of ER stress on
mitochondria-mediated cell death caused by b-lap treatment.
Figures 6D, E and F show that pretreatment with Sal significantly
suppressed b-lap-induced disruption of mitochondrial membrane
potential, mitochondrial translocation of cleaved Bax and the
nuclear translocation of AIF and Endo G. These results clearly
indicate that ER stress is important for mitochondria-mediated cell
death caused by b-lap treatment.
Because ER stress has been known to be one of the main causes
of JNK activation [23–29], we further assessed the relationship
between ER stress and JNK activation using a pharmacological
inhibitor of ER stress and JNK2 siRNA. As shown in Figures 6G
and H, siRNA targeting JNK2 did not attenuate the phosphor-
ylation of eIF2a caused by b-lap treatment, whereas pretreat-
ment with Sal significantly prevented the activation of JNK. These
findings suggest that ER stress is strictly necessary for the activa-
tion of JNK after b-lap treatment.
Discussion
b-lap, a novel anticancer drug, is bioreductive agent which is
reduced in cells by the reductive enzyme, NQO1 (1–6). The
reduction of b-lap induces Ca
2+ dependent hyperactivation of Poly
(ADP-Ribose) polymerase-1 (PARP-1) and DNA damage, which
subsequently contributesto apoptoticornecrotic cell death [30–35].
In the present work, b-lap preferentially induced clonogenic and
apoptotic cell death in NQO1
+-MDA-MB-231 cells compared to
NQO1
2-MDA-MB-231 cells (Fig. 1). These results are consistent
with previous data on the role played by NOQ1 in mediation of b-
lap toxicity [30–34,36]. Because NQO1 is abundantly expressed in
a variety of cancer tissues, it may be surmised that cancer tissues can
be damaged selectively by b-lap. However, the molecular signaling
pathways underlyingthetherapeutic effectsof b-lap on solid cancers
have not yet been clearly understood. In the present study, we
demonstrate that the nuclear translocation of AIF and Endo G is
critical for b-lap-induced caspase-independent cell death. We also
show that JNK activation triggered by ER stress is essential for
mitochondria-mediated cell death caused by b-lap.
Many anti-cancer drugs have been suggested to induce
apoptosis of cancer cells via mitochondrial dysfunction linked to
caspase-dependent/independent pathways [37,38]. Although b-
lap has been previously reported to induce apoptotic cell death in a
caspase-dependent manner [39,40], the apoptotic process caused
by b-lap in the present work, appears to be caspase-independent,
because a broad spectrum caspase inhibitor failed to suppress b-
lap-induced apoptosis (Fig. 1).
AIF and Endo G are well known to be involved in a caspase-
independent apoptotic pathway [7,10,11]. Death stimuli acceler-
ate the release of AIF and Endo G from mitochondria, and then
these proteins are translocated to the nucleus, where they initiate
nuclear condensation and DNA fragmentation [7,10,11]. In
agreement with these reports, we observed that AIF and Endo
G are translocated to the nucleus, and the activities of these pro-
teins are also required for b-lap-induced cell death (Fig. 2).
Bcl-2 family plays key roles in the regulation of mitochondria-
mediated cell death [6]. The anti-apoptotic Bcl-2 family proteins
including Bcl-2, Bcl-xL and Mcl-1 are involved in cell survival [6].
Recent reports demonstrated that STAT3 (signal transducer and
activator of transcription 3) increases the transcription and
subsequent expression of Bcl-2, Bcl-xL and Mcl-1 [41–43]. As
this pro-oncogenic transcription factor is constitutively activated in
many types of cancer, it is highly likely that STAT3 also plays an
important role in cell proliferation, cell survival and tumor
transformation [42–44]. Moreover, STAT3 has been suggested to
be involved in IL-6-induced resistance to b-lap in prostatic cancer
cells [41]. In response to diverse stimuli, Bax is activated,
translocated to the outer mitochondrial membrane, and oligomer-
ized, resulting in the disruption of mitochondrial integrity and
release of mitochondrial apoptogenic proteins to the cytosol [12–
14]. In particular, N-terminal cleavage of native Bax (21 kDa) into
an 18 kDa form by calpain has been reported to occur in cancer
cells treated with a variety of chemotherapeutic drugs [15,16].
This cleaved form of Bax is more potent than the native form for
disruption of mitochondrial membrane potential and induction of
apoptotic cell death. In agreement with these reports, we observed
that b-lap leads to Bax cleavage without alterations in the protein
level of Bcl-2. We also found that the cleaved form of Bax is
translocated to mitochondria upon treatment with b-lap (Fig. 3).
It has already been suggested that b-lap activates MAPKs in
human cancer cells [45,46]. In agreement with these reports, we
observed that all MAPKs are activated soon after b-lap treatment
(Fig. 4). In particular, inhibition of JNK by a specific inhibitor
effectively attenuates all of b-lap-induced clonogenic, apoptotic
cell death, disruption of mitochondrial membrane potential,
cleavage of Bax, mitochondrial translocation of cleaved Bax, and
nuclear translocation of AIF and Endo G. However, inhibition of
p38 MAPK or ERK slightly inhibits these events triggered by
b-lap, indicating that the activations of both p38 MAPK and ERK
are weakly associated with b-lap-induced cell death. These
observations are consistent with a previous report that JNK plays
a critical role during b-lap-induced apoptosis in human cancer
cells [46]. Although the cited report did not show the downstream
targets of JNK during b-lap-induced apoptosis, our results in the
present study clearly indicated that JNK activation is required for
activation of the mitochondria-mediated cell death pathway in
response to b-lap treatment. Additionally, since calpain partici-
pating in the proteolytic cleavage of Bax has been reported to be
activated indirectly by JNK [47,48], and b-lap was also suggested
to activate calpain [1,2,5], further studies are required to clarify
the role of JNK in calpain-mediated Bax cleavage occurring in
response to b-lap. Furthermore, we found that inhibition of JNK2
is more effective than that of JNK1 in blocking all of b-lap-induced
apoptosis, loss of mitochondrial membrane potential, mitochon-
drial translocation of cleaved Bax, and nuclear translocation of
AIF and Endo G (Fig. 5). These findings are consistent with the
results of a previous study that JNK2 activity was required for
mitochondria-mediated apoptosis in response to liver ischemia
[49]. Furthermore, because JNK1 plays a crucial role in controlling
systemic glucose and lipid metabolism involved in energy ex-
penditure [50], and was proposed as a candidate protein kinase that
can phosphorylate Zfra (zinc finger-like protein that regulates
representative a typical experiment conducted three times. (E) NQO1
+-MDA-MB-231 cells transfected with JNK1 or JNK2 siRNA were treated with
5 mMo fb-lap for 6 h. Nuclear fractions were prepared and subjected to Western blot analysis using anti-AIF, -Endo G, and -Nucleoporin p62
antibodies. Nucleoporin p62 was used as a nuclear marker protein. The data are representative a typical experiment conducted three times. The data
are representative of a typical experiment conducted three times with similar results.
doi:10.1371/journal.pone.0021533.g005
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+-MDA-MB-231 cells were treated with 5 mMo f
b-lap for the indicated times. Cell lysates were subjected to Western blot analysis with anti-phospho-eIF2a, -eIF2a, -GRP94 and b-actin antibodies. b-
actin was used as a loading control. The data represent a typical experiment conducted three times with similar results. (B) NQO1
+-MDA-MB-231 cells
were treated with 5 mMo fb-lap in the presence or absence of Salubrinal (30 mM). Cells were allowed to grow for 10 to 14 days and were stained with
0.5% crystal violet and scored for colony formation. Results from three independent experiments are expressed as means 6 SEM. *Significant
difference between cells in the presence or absence of Salubrinal after b-lap treatment, at p,0.05. (C) NQO1
+-MDA-MB-231 cells were treated with
5 mMo fb-lap for 18 h in the presence or absence of Salubrinal (30 mM). Cells were stained with PI and the percentage of cells with a sub-G1 DNA
content was measured via flow cytometric analysis. Results from three independent experiments are expressed as the means 6 SEM. *Significant
difference between the cells in the presence or absence of Salubrinal after b-lap treatment at p,0.05. (D) NQO1
+-MDA-MB-231 cells were treated
with 5 mMo fb-lap for 6 h in the presence or absence of Salubrinal (30 mM). Cells were loaded with 30 nM of DiOC6(3) for a further 30 min of the
treatments. After removal of medium, the concentration of retained DiOC6(3) was measured by flow cytometry. Results from three independent
experiments are expressed as means 6 SEMs. *Significant difference between the cells in the presence or absence of Salubirnal after b-lap treatment
at p,0.05. (E) NQO1
+-MDA-MB-231 cells were treated with 5 mMo fb-lap for 6 h in the presence or absence of Salubrinal (30 mM). Mitochondrial
fractions were prepared and subjected to Western blot analysis using anti-Bax and -mitochondrial HSP70 antibodies. Mitochondrial HSP70 was used
as a mitochondrial marker protein. The data are representative a typical experiment conducted three times. (F) NQO1
+-MDA-MB-231 cells were
treated with 5 mMo fb-lap for 6 h in the presence or absence of Salubrinal (30 mM). Nuclear fractions were prepared and subjected to Western blot
analysis using anti-AIF, -Endo G, and -Nucleoporin p62 antibodies. Nucleoporin p62 was used as a nuclear marker protein. The data are representative
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[51], there is a possiblity that JNK1 can partially affect b-lap-
induced mitochondrial apoptosis via regulation of metabolic path-
ways or Zfra phosphorylation.
It is noteworthy that b-lap-induced activation of JNK started to
increase within 30 min, and lasted for 1 h and then subsequently
decreased (Fig. 4). This reduction of JNK activity in 1 h following
b-lap treatment may be due to the activation of phosphatases, such
as a MAPK phosphatase 2 (MKP2) and -7 (MKP7), which have
been reported to regulate the intracellular MAPK signaling path-
ways [52-54]. Therefore, because there is a reasonable possibility
that JNK activity can be regulated by a negative feedback loop
between JNK and these MAPK phosphatases in response to b-lap,
additional studies are needed to define the precise role played by
MKP2 or MKP7 in b-lap-treated cells.
It has been clearly demonstrated that excessive ER stress can
lead to apoptotic cell death [23–26]. Consistent with these reports,
we found that b-lap induces the phosphorylation of eIF2a, and
raises the expression level of GRP94 in NQO1
+-MDA-MB-231
cells. We also observed that inhibition of ER stress by pretreat-
ment with Sal, an ER stress inhibitor, efficiently attenuates
mitochondria-mediated cell death caused by b-lap. These results
suggested that the cell death induced by b-lap treatment is mainly
due to induction of ER stress. The activation of JNK by ER stress
has been attributed to activation of IRE1/TRAF2/ASK1 path-
way [23–26]. In response to ER stress, IRE1 is activated by
autophosphorylation, and then recruits TRAF2 (tumor necrosis
factor receptor-associated factor 2), which subsequently activates
ASK1 leading to JNK activation. In agreement with previous
reports, our results showed that the suppression of ER stress by Sal
effectively blocked JNK activation and subsequent apoptotic cell
death caused by b-lap, whereas the inhibition of JNK by pre-
treatment with JNK2 siRNA did not attenuate b-lap-induced ER
stress (Fig. 6). These results suggested that JNK activation acts on
downstream of the ER stress to induce mitochondria-mediated cell
death in response to b-lap treatment.
In conclusion, in the present study, we demonstrate here that
b-lap significantly induces apoptotic cell death in a NQO1-
dependent manner, and also suggest that ER stress-induced JNK
activation is a critical requirement for mitochondria-mediated cell
death caused by b-lap (Fig. 7). Better insights into the signaling
pathways underlying the anti-cancer activity of b-lap will lead to
advancement in treatment strategies of NQO1-directed cancer
therapy using the novel drug.
Materials and Methods
Reagents
b-lap was purchased from Biomol (Plymouth Meeting, PA), and
was dissolved in DMSO. Antibodies against p38 MAPK, JNK2,
JNK1/2, ERK1/2, Bax, Bcl2, AIF and Nucleoporin p62 were
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
An antibody against mitochondrial heat shock protein 70 (HSP70)
was the product of Affinity Bioreagents (Golden, CO). Anti-b-
actin, -rabbit IgG, and -mouse IgG were purchased from Sigma
(St. Lous, MO). Antibodies against phospho-p38 MAPK (Thr180/
Tyr182), phospho-JNK1/2 (Thr183/Tyr185), phospho-ERK1/2
(Thr202/Tyr204), phosphor-eIF2a (Ser51), and eIF2a were
obtained from Cell Signaling Technology (Beverly, MA). Inhib-
itors specific to JNK (SP600125), MEK/ERK (PD98059), p38
MAPK (SB203580), caspases (z-VAD-fmk) and ER stress (Salu-
brinal) were purchased from Calbiochem (San Diego, CA).
Cell culture
Parental NQO1
2-MDA-MB-231 human breast cancer cells,
which are NQO1-deficient, and NQO1
+-MDA-MB-231 human
breast cancer cells, which are stably transfected with NQO1,
were obtained from Dr. David Boothman, University of Texas
Southwestern Medical Center, Dallas, TX. Cells were cultured in
RPMI 1640 medium (Gibco BRL, Grand Island, NY) supple-
mented with 10% (v/v) bovine calf serum (Gibco BRL), penicillin
(50 units/ml), and streptomycin (50 mg/ml), in a 37uC incubator
under a mixture of 95% air and 5% CO2 (both v/v).
a typical experiment conducted three times. The data are representative of a typical experiment conducted three times with similar results. (G)
NQO1
+-MDA-MB-231 cells transfected with JNK2 siRNA were treated with 5 mMo fb-lap for 3 h. Cell lysates were subjected to Western blot analysis
with anti-phospho-eIF2a, -eIF2a and -b-actin antibodies. b-actin was used as a loading control. The data represent a typical experiment conducted
three times with similar results. (H) NQO1
+-MDA-MB-231 cells were treated with 5 mMo fb-lap for 30 min in the presence or absence of Salubrinal
(30 mM). Cell lysates were subjected to Western blot analysis with anti-phospho-JNK1/2, -JNK1/2, and -b-actin antibodies. b-actin was used as a
loading control. The data represent a typical experiment conducted three times with similar results.
doi:10.1371/journal.pone.0021533.g006
Figure 7. Schematic model of mitochondria-mediated cell
death triggered by b-lap. b-lap induces mitochondrial apoptotic
cell death in a NQO1-dependent manner. The induction of ER stress by
b-lap is substantially required for JNK activation which triggers
mitochondria-mediated cell death pathway. In detail, JNK activation
induces cleavage of Bax and mitochondrial translocation of cleaved Bax,
which causes disruption of mitochondrial membrane potential, and
subsequent nuclear translocation of AIF and Endo G. Understanding
these signaling pathways that we elucidated in this study may provide
useful insights into improvement in therapeutic efficacy of the design
of NQO1-targeted cancer therapies.
doi:10.1371/journal.pone.0021533.g007
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RNA interference with siRNAs was carried out using double-
stranded RNA molecules. AIF (59-GCA AGU UAC UUA UCA
AGC UTT-39) and JNK2 (59-CUG UAA CUG UUG AGA UGU
ATT-39) siRNAs was purchased from Bioneer Corporation
(Daejeon, Korea). Endo G (59-GGA ACA ACC UGG AGA
AAU ATT-39) and JNK1 (59- GAC CUA AAU AUG CUG GAU
ATT-39) siRNAs were the products of Samchully Pharm (Seoul,
Korea). An unrelated control siRNA (59-CCA CTA CCT GAG
CAC CCA G-39) that targeted green fluorescent protein DNA
sequence was used as a control. For transfection, cells were seeded
on 60 mm dishes and transfected at 30% confluency with the
siRNA duplexes (100 nM), using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) in accordance with the manufacturer’s instructions.
Assays were performed 24 h after transfection.
Quantification of clonogenic death
Various numbers of cells were plated on 60 mm dishes and
treated with a range of doses of b-lap at 0 to 10 mM, or 5 mMo fb-
lap, and followed by incubation for 14 days at 37uC in 5% CO2
incubator. Prior to counting colonies, the culture medium was
decanted and the cells were fixed in 95% methanol and stained
with 0.5% crystal violet, and the numbers of colonies (.50 cells)
from triplicate dishes were counted. Mean colony numbers relative
to unirradiated colony numbers were plotted.
Quantification of cell death
Cells were collected by trypsinization, washed 2 times with PBS,
resuspended in 1 ml PBS containing 0.1% Triton X-100, 0.1 mM
EDTA, 10 mg/ml DNase-free RNase A, and 2 mg/ml propidium
iodide (PI), and incubated for 1 h in the dark at 37uC. Apoptotic
cells were detected on a flow cytometer using a FACSCalibur
(Becton Dickinson, San Jose, CA). Apoptosis was measured as the
percentage of sub-G1 cell population.
Western blot analysis
Cells were treated with lysis buffer [40 mmol/L Tris-Cl
(pH 8.0), 120 mmol/L NaCl, and 0.1% NP40] supplemented
with protease inhibitors, then centrifuged for 15 min at 12,0006g.
Proteins were separated via SDS-PAGE and transferred to
nitrocellulose membranes (Bio-Rad, Hercules, CA). The mem-
branes were blocked with 5% nonfat dry milk in Tris-buffered
saline and subsequently incubated for 1 h with primary antibodies
at room temperature. Blots were developed with peroxidase-
conjugated secondary antibody, and the proteins were visualized
via enhanced chemiluminescence (Amersham Biosciences, Piscat-
away, NJ) according to the manufacturer’s recommendations.
Confocal microscopy
b-lap-treated cells were washed twice in ice-cold PBS prior to
fixation in ice-cold methanol. After blocking with 2% (w/v) bovine
serum albumin in PBS containing 0.2% (v/v) Triton X-100, cells
were incubated for 1 h with primary antibodies against AIF and
Endo G. Cells were then washed three times in blocking solution
and incubated for an additional hour with secondary antibody
conjugated to FITC (Molecular Probes). Nuclei were then stained
with PI (Sigma) for 10 minutes. After three further washes with
PBS, coverslips were mounted onto microscope slides using the
ProLong Antifade mounting reagent (Molecular Probes). Slides
were viewed using a confocal laser-scanning microscope (Nikon
TE-2000E, Tokyo, Japan).
Measurement of mitochondrial membrane potential
Cells were incubated for 30 min in 30 nM of DiOC6(3) (Mo-
lecular Probes, Eugene, OR) at 37uC, harvested via trypsinization,
and washed three times with cold PBS. Mitochondrial membrane
potential was determined by flow cytometry.
Preparation of mitochondrial and nuclear fractions
Cells were collected and washed twice in ice-cold PBS,
resuspended in isotonic homogenization buffer [250 mM sucrose,
10 mM KCl, 1.5 mM MgCl2, 1 mM Na-EDTA, 1 mM dithio-
threitol, 0.1 mM phenylmethylsulfonylfluoride, 10 mM Tris-HCl
(pH 7.4)], incubated on ice for 20 min, and homogenized using a
Dounce glass homogenizer fitted with a loose pestle (Wheaton,
Millville, NJ) (70 strokes). Cell homogenates were spun at 306gt o
remove any unbroken cells. Supernatants were then respun for
10 min at 7506g to separate nuclear and mitochondrial fractions.
Each nuclear fraction (a pellet) was washed three times in
homogenization buffer, and resuspended in lysis buffer [50 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 1% (v/v) NP40, 0.5% (w/v)
sodium deoxycholate] containing protease inhibitors, prior to
Western blot analysis. After pelleting of the nuclear fraction, the
supernatant was further subjected to 30 min of centrifugation at
14,0006 g to pellet a mitochondria-rich fraction. Pellets were
washed once in homogenization buffer, and then resuspended in
lysis buffer [150 mM NaCl, 50 mM Tris-HCl (pH 7.5), 1% (v/v)
NP40, 0.25% (w/v) sodium deoxycholate, and 1 mM EGTA],
with protease inhibitors, prior to Western blot analysis.
Statistical analysis
All data presented are representative of at least three separate
experiments. Comparisons among groups were analyzed using
Student’s t-test (SPSS Statistics version 17.0, Chicago, IL). p values
,0.05 were considered to be significant.
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